* We recommend a score >= 0.08 for meaningful Gene-Disease associations
GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | ![]() | DisGeNet_sourceDB |
238 | ALK | C0027819 | Neuroblastoma | 0.443283897861771 | BEFREE;CTD_human;GAD;LHGDN;ORPHANET |
238 | ALK | C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 0.304596212183324 | BEFREE;CTD_human;LHGDN |
238 | ALK | C0007131 | Non-Small Cell Lung Carcinoma | 0.28 | BEFREE;CTD_human |
238 | ALK | C0152013 | Adenocarcinoma of lung (disorder) | 0.226648498068671 | BEFREE;CTD_human |
238 | ALK | C0334121 | Inflammatory Myofibroblastic Tumor | 0.218406694542278 | BEFREE;ORPHANET |
238 | ALK | C0079744 | Diffuse Large B-Cell Lymphoma | 0.209586726692824 | BEFREE;CTD_human;LHGDN |
238 | ALK | C0027627 | Neoplasm Metastasis | 0.20796707674218 | BEFREE;CTD_human |
238 | ALK | C1332079 | Anaplastic Large Cell Lymphoma, ALK-Positive | 0.207417623173754 | BEFREE;ORPHANET |
238 | ALK | C0036341 | Schizophrenia | 0.202681755307501 | BEFREE;GAD;PSYGENET |
238 | ALK | C0007621 | Neoplastic Cell Transformation | 0.202407028523288 | CTD_human;GAD |
238 | ALK | C0007134 | Renal Cell Carcinoma | 0.201923087489492 | BEFREE;CTD_human |
238 | ALK | C1333294 | ALK positive large B-cell lymphoma | 0.201098907136852 | BEFREE;ORPHANET |
238 | ALK | C0238463 | Papillary thyroid carcinoma | 0.200549453568426 | BEFREE;ORPHANET |
238 | ALK | C0278601 | Inflammatory Breast Carcinoma | 0.200549453568426 | BEFREE;CTD_human |
238 | ALK | C0006118 | Brain Neoplasms | 0.200274726784213 | BEFREE;CTD_human |
238 | ALK | C0085269 | Plasma Cell Granuloma, Pulmonary | 0.200274726784213 | BEFREE;CTD_human |
238 | ALK | C2931189 | Neural crest tumor | 0.200274726784213 | BEFREE;ORPHANET |
238 | ALK | C2751681 | NEUROBLASTOMA, SUSCEPTIBILITY TO, 3 | 0.2 | UNIPROT |
238 | ALK | C0001973 | Alcoholic Intoxication, Chronic | 0.2 | PSYGENET |
238 | ALK | C0011570 | Mental Depression | 0.2 | PSYGENET |
238 | ALK | C0011581 | Depressive disorder | 0.2 | PSYGENET |
238 | ALK | C0018199 | Granuloma, Plasma Cell | 0.2 | CTD_human |
238 | ALK | C0027643 | Neoplasm Recurrence, Local | 0.2 | CTD_human |
238 | ALK | C0027766 | Nervous System Neoplasms | 0.2 | HPO |
238 | ALK | C0241577 | Catecholamines urine increased | 0.2 | HPO |
238 | ALK | C0242379 | Malignant neoplasm of lung | 0.0441654997236792 | BEFREE;GAD |
238 | ALK | C0024299 | Lymphoma | 0.0419183549660663 | BEFREE;LHGDN |
238 | ALK | C0001418 | Adenocarcinoma | 0.0383818818778869 | BEFREE;GAD;LHGDN |
238 | ALK | C0684249 | Carcinoma of lung | 0.0304946730476541 | BEFREE |
238 | ALK | C1306460 | Primary malignant neoplasm of lung | 0.0304946730476541 | BEFREE |
238 | ALK | C0700095 | Central neuroblastoma | 0.024725410579179 | BEFREE |
238 | ALK | C0024121 | Lung Neoplasms | 0.0199177658263402 | BEFREE;GAD;LHGDN |
238 | ALK | C0596263 | Carcinogenesis | 0.013736339210655 | BEFREE |
238 | ALK | C0079731 | B-Cell Lymphomas | 0.00986145347703711 | BEFREE;LHGDN |
238 | ALK | C0079772 | T-Cell Lymphoma | 0.00850217493328885 | BEFREE;LHGDN |
238 | ALK | C0019829 | Hodgkin Disease | 0.00795272136486265 | BEFREE;LHGDN |
238 | ALK | C0017636 | Glioblastoma | 0.0076636392033323 | BEFREE;LHGDN |
238 | ALK | C0024305 | Lymphoma, Non-Hodgkin | 0.00657908744379715 | BEFREE;LHGDN |
238 | ALK | C1321546 | Anaplastic large B-cell lymphoma | 0.005494535684262 | BEFREE |
238 | ALK | C0026769 | Multiple Sclerosis | 0.004814057046576 | GAD |
238 | ALK | C0220650 | Metastatic malignant neoplasm to brain | 0.0046703553316227 | BEFREE |
238 | ALK | C0079774 | Peripheral T-Cell Lymphoma | 0.0038461749789834 | BEFREE |
238 | ALK | C0598766 | Leukemogenesis | 0.0035714481947703 | BEFREE |
238 | ALK | C1336548 | Systemic Anaplastic Large Cell Lymphoma | 0.0035714481947703 | BEFREE |
238 | ALK | C0007137 | Squamous cell carcinoma | 0.0032967214105572 | BEFREE |
238 | ALK | C1301362 | Lymphoma, Primary Cutaneous Anaplastic Large Cell | 0.0030219946263441 | BEFREE |
238 | ALK | C0242596 | Neoplasm, Residual | 0.00300763924902685 | BEFREE;LHGDN |
238 | ALK | C0009402 | Colorectal Carcinoma | 0.002747267842131 | BEFREE |
238 | ALK | C0008626 | Congenital chromosomal disease | 0.0024725410579179 | BEFREE |
238 | ALK | C1527249 | Colorectal Cancer | 0.0024725410579179 | BEFREE |
238 | ALK | C0023434 | Chronic Lymphocytic Leukemia | 0.002407028523288 | GAD |
238 | ALK | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
238 | ALK | C0280100 | solid tumor | 0.0021978142737048 | BEFREE |
238 | ALK | C1261473 | Sarcoma | 0.0021978142737048 | BEFREE |
238 | ALK | C1332078 | Anaplastic large cell lymphoma, ALK negative | 0.0021978142737048 | BEFREE |
238 | ALK | C3899155 | Familial Neuroblastoma | 0.0019230874894917 | BEFREE |
238 | ALK | C0035412 | Rhabdomyosarcoma | 0.0016483607052786 | BEFREE |
238 | ALK | C0206182 | Lymphomatoid Papulosis | 0.0016483607052786 | BEFREE |
238 | ALK | C0149782 | Squamous cell carcinoma of lung | 0.0013736339210655 | BEFREE |
238 | ALK | C0678222 | Breast Carcinoma | 0.0013736339210655 | BEFREE |
238 | ALK | C0006142 | Malignant neoplasm of breast | 0.0010989071368524 | BEFREE |
238 | ALK | C0023418 | leukemia | 0.0010989071368524 | BEFREE |
238 | ALK | C0024314 | Lymphoproliferative Disorders | 0.0010989071368524 | BEFREE |
238 | ALK | C0494165 | Secondary malignant neoplasm of liver | 0.0010989071368524 | BEFREE |
238 | ALK | C0549473 | Thyroid carcinoma | 0.0010989071368524 | BEFREE |
238 | ALK | C1333064 | Classical Hodgkin's Lymphoma | 0.0010989071368524 | BEFREE |
238 | ALK | C2239176 | Liver carcinoma | 0.0010989071368524 | BEFREE |
238 | ALK | C0024302 | Reticulosarcoma | 0.0008241803526393 | BEFREE |
238 | ALK | C0025202 | melanoma | 0.0008241803526393 | BEFREE |
238 | ALK | C0037054 | Sickle Cell Trait | 0.0008241803526393 | BEFREE |
238 | ALK | C0153676 | Secondary malignant neoplasm of lung | 0.0008241803526393 | BEFREE |
238 | ALK | C0206623 | Adenosquamous carcinoma | 0.0008241803526393 | BEFREE |
238 | ALK | C0278704 | Malignant Childhood Neoplasm | 0.0008241803526393 | BEFREE |
238 | ALK | C0686619 | Secondary malignant neoplasm of lymph node | 0.0008241803526393 | BEFREE |
238 | ALK | C0729233 | Dissecting aneurysm of the thoracic aorta | 0.0008241803526393 | BEFREE |
238 | ALK | C0854988 | Adenocarcinoma of lung, stage IV | 0.0008241803526393 | BEFREE |
238 | ALK | C0007115 | Malignant neoplasm of thyroid | 0.0005494535684262 | BEFREE |
238 | ALK | C0007130 | Mucinous Adenocarcinoma | 0.0005494535684262 | BEFREE |
238 | ALK | C0007140 | Carcinosarcoma | 0.0005494535684262 | BEFREE |
238 | ALK | C0015230 | Exanthema | 0.0005494535684262 | BEFREE |
238 | ALK | C0024301 | Lymphoma, Follicular | 0.0005494535684262 | BEFREE |
238 | ALK | C0027831 | Neurofibromatosis 1 | 0.0005494535684262 | BEFREE |
238 | ALK | C0029925 | Ovarian Carcinoma | 0.0005494535684262 | BEFREE |
238 | ALK | C0032227 | Pleural effusion disorder | 0.0005494535684262 | BEFREE |
238 | ALK | C0037579 | Soft Tissue Neoplasms | 0.0005494535684262 | BEFREE |
238 | ALK | C0085281 | Addictive Behavior | 0.0005494535684262 | BEFREE |
238 | ALK | C0149925 | Small cell carcinoma of lung | 0.0005494535684262 | BEFREE |
238 | ALK | C0178874 | Tumor Progression | 0.0005494535684262 | BEFREE |
238 | ALK | C0205697 | Carcinoma, Spindle-Cell | 0.0005494535684262 | BEFREE |
238 | ALK | C0206644 | Histiocytoma, Benign Fibrous | 0.0005494535684262 | BEFREE |
238 | ALK | C0206718 | Ganglioneuroblastoma | 0.0005494535684262 | BEFREE |
238 | ALK | C0220612 | childhood non-Hodgkin's lymphoma | 0.0005494535684262 | BEFREE |
238 | ALK | C0220654 | Meningeal Carcinomatosis | 0.0005494535684262 | BEFREE |
238 | ALK | C0235598 | HODGKIN'S-LIKE | 0.0005494535684262 | BEFREE |
238 | ALK | C0238461 | Anaplastic thyroid carcinoma | 0.0005494535684262 | BEFREE |
238 | ALK | C0268621 | Hepatic methionine adenosyltransferase deficiency | 0.0005494535684262 | BEFREE |
238 | ALK | C0332996 | Persistent embryonic structure | 0.0005494535684262 | BEFREE |
238 | ALK | C0376545 | Hematologic Neoplasms | 0.0005494535684262 | BEFREE |
238 | ALK | C0546837 | Malignant neoplasm of esophagus | 0.0005494535684262 | BEFREE |
238 | ALK | C0677932 | Progressive Neoplastic Disease | 0.0005494535684262 | BEFREE |
238 | ALK | C0677936 | Refractory cancer | 0.0005494535684262 | BEFREE |
238 | ALK | C0686377 | CNS metastases | 0.0005494535684262 | BEFREE |
238 | ALK | C0751691 | Perineurioma | 0.0005494535684262 | BEFREE |
238 | ALK | C0848332 | Spots on skin | 0.0005494535684262 | BEFREE |
238 | ALK | C1266002 | Non-small cell carcinoma | 0.0005494535684262 | BEFREE |
238 | ALK | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0005494535684262 | BEFREE |
238 | ALK | C4049328 | Kidney Medullary Carcinoma | 0.0005494535684262 | BEFREE |
238 | ALK | C3539781 | Progressive cGVHD | 0.0005494535684262 | BEFREE |
238 | ALK | C3281200 | LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS | 0.0002747267842131 | BEFREE |
238 | ALK | C4086165 | Childhood Neuroblastoma | 0.0002747267842131 | BEFREE |
238 | ALK | C4049711 | Lepidic Predominant Adenocarcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C4024986 | Congenital neuroblastoma | 0.0002747267842131 | BEFREE |
238 | ALK | C3811653 | Experimental Organism Basal Cell Carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C3536893 | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 0.0002747267842131 | BEFREE |
238 | ALK | C3472614 | Plasmablastic lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1835009 | MESOMELIC DYSPLASIA, KANTAPUTRA TYPE | 0.0002747267842131 | BEFREE |
238 | ALK | C2939461 | Myeloid neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C2363142 | T-Cell Prolymphocytic Leukemia | 0.0002747267842131 | BEFREE |
238 | ALK | C2145472 | Urothelial Carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1850900 | Familial primary gastric lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1845055 | ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED | 0.0002747267842131 | BEFREE |
238 | ALK | C0000744 | Abetalipoproteinemia | 0.0002747267842131 | BEFREE |
238 | ALK | C0001546 | Adjustment Disorders | 0.0002747267842131 | BEFREE |
238 | ALK | C0001956 | alcohol use disorder | 0.0002747267842131 | BEFREE |
238 | ALK | C0002690 | Amputation Stumps | 0.0002747267842131 | BEFREE |
238 | ALK | C0004114 | Astrocytoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0004134 | Ataxia | 0.0002747267842131 | BEFREE |
238 | ALK | C0004135 | Ataxia Telangiectasia | 0.0002747267842131 | BEFREE |
238 | ALK | C0006111 | Brain Diseases | 0.0002747267842131 | BEFREE |
238 | ALK | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
238 | ALK | C0007120 | Bronchioloalveolar Adenocarcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0007129 | Merkel cell carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0007133 | Carcinoma, Papillary | 0.0002747267842131 | BEFREE |
238 | ALK | C0007138 | Carcinoma, Transitional Cell | 0.0002747267842131 | BEFREE |
238 | ALK | C0007682 | CNS disorder | 0.0002747267842131 | BEFREE |
238 | ALK | C0007758 | Cerebellar Ataxia | 0.0002747267842131 | BEFREE |
238 | ALK | C0011265 | Presenile dementia | 0.0002747267842131 | BEFREE |
238 | ALK | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0002747267842131 | BEFREE |
238 | ALK | C0017075 | Ganglioneuroma | 0.0002747267842131 | BEFREE |
238 | ALK | C0017638 | Glioma | 0.0002747267842131 | BEFREE |
238 | ALK | C0018790 | Cardiac Arrest | 0.0002747267842131 | BEFREE |
238 | ALK | C0019163 | Hepatitis B | 0.0002747267842131 | BEFREE |
238 | ALK | C0019569 | Hirschsprung Disease | 0.0002747267842131 | BEFREE |
238 | ALK | C0019623 | Malignant histiocytosis | 0.0002747267842131 | BEFREE |
238 | ALK | C0019693 | HIV Infections | 0.0002747267842131 | BEFREE |
238 | ALK | C0020532 | Hypersplenism | 0.0002747267842131 | BEFREE |
238 | ALK | C0020981 | Angioimmunoblastic Lymphadenopathy | 0.0002747267842131 | BEFREE |
238 | ALK | C0021051 | Immunologic Deficiency Syndromes | 0.0002747267842131 | BEFREE |
238 | ALK | C0021294 | Infant, Premature | 0.0002747267842131 | BEFREE |
238 | ALK | C0021831 | Intestinal Diseases | 0.0002747267842131 | BEFREE |
238 | ALK | C0023440 | Acute Erythroblastic Leukemia | 0.0002747267842131 | BEFREE |
238 | ALK | C0023448 | Lymphoid leukemia | 0.0002747267842131 | BEFREE |
238 | ALK | C0023449 | Acute lymphocytic leukemia | 0.0002747267842131 | BEFREE |
238 | ALK | C0023493 | Adult T-Cell Lymphoma/Leukemia | 0.0002747267842131 | BEFREE |
238 | ALK | C0023903 | Liver neoplasms | 0.0002747267842131 | BEFREE |
238 | ALK | C0024117 | Chronic Obstructive Airway Disease | 0.0002747267842131 | BEFREE |
238 | ALK | C0024899 | Mastocytosis | 0.0002747267842131 | BEFREE |
238 | ALK | C0026948 | Mycosis Fungoides | 0.0002747267842131 | BEFREE |
238 | ALK | C0027654 | Embryonal Neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C0027960 | Nevus | 0.0002747267842131 | BEFREE |
238 | ALK | C0030297 | Pancreatic Neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C0032226 | Pleural Diseases | 0.0002747267842131 | BEFREE |
238 | ALK | C0032326 | Pneumothorax | 0.0002747267842131 | BEFREE |
238 | ALK | C0035078 | Kidney Failure | 0.0002747267842131 | BEFREE |
238 | ALK | C0035335 | Retinoblastoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0035369 | Retroviridae Infections | 0.0002747267842131 | BEFREE |
238 | ALK | C0037274 | Dermatologic disorders | 0.0002747267842131 | BEFREE |
238 | ALK | C0085584 | Encephalopathies | 0.0002747267842131 | BEFREE |
238 | ALK | C0085648 | Synovial Cyst | 0.0002747267842131 | BEFREE |
238 | ALK | C0149678 | Epstein-Barr Virus Infections | 0.0002747267842131 | BEFREE |
238 | ALK | C0152268 | Hodgkin's disease, nodular sclerosis (clinical) | 0.0002747267842131 | BEFREE |
238 | ALK | C0154038 | Benign neoplasm of thyroid gland | 0.0002747267842131 | BEFREE |
238 | ALK | C0205696 | Anaplastic carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0206062 | Lung Diseases, Interstitial | 0.0002747267842131 | BEFREE |
238 | ALK | C0206629 | Pulmonary Blastoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0206630 | Endometrial Stromal Sarcoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0206654 | Leiomyomatosis | 0.0002747267842131 | BEFREE |
238 | ALK | C0206655 | Alveolar rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0206656 | Rhabdomyosarcoma, Embryonal | 0.0002747267842131 | BEFREE |
238 | ALK | C0206701 | Cystadenocarcinoma, Serous | 0.0002747267842131 | BEFREE |
238 | ALK | C0206703 | Carcinoma, Giant Cell | 0.0002747267842131 | BEFREE |
238 | ALK | C0206704 | Carcinoma, Large Cell | 0.0002747267842131 | BEFREE |
238 | ALK | C0206708 | Cervical Intraepithelial Neoplasia | 0.0002747267842131 | BEFREE |
238 | ALK | C0206754 | Neuroendocrine Tumors | 0.0002747267842131 | BEFREE |
238 | ALK | C0233629 | Thinking and speaking disturbances | 0.0002747267842131 | BEFREE |
238 | ALK | C0235593 | Thoracic lymphadenopathy | 0.0002747267842131 | BEFREE |
238 | ALK | C0235974 | Pancreatic carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0238305 | Sickle cell nephropathy | 0.0002747267842131 | BEFREE |
238 | ALK | C0238462 | Medullary carcinoma of thyroid | 0.0002747267842131 | BEFREE |
238 | ALK | C0242647 | Mucosa-Associated Lymphoid Tissue Lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0262584 | Carcinoma, Small Cell | 0.0002747267842131 | BEFREE |
238 | ALK | C0265122 | Disorder of pericardium | 0.0002747267842131 | BEFREE |
238 | ALK | C0265783 | Congenital hypoplasia of lung | 0.0002747267842131 | BEFREE |
238 | ALK | C0275524 | Coinfection | 0.0002747267842131 | BEFREE |
238 | ALK | C0278987 | Non-small cell lung cancer metastatic | 0.0002747267842131 | BEFREE |
238 | ALK | C0279557 | Adenosquamous cell lung cancer | 0.0002747267842131 | BEFREE |
238 | ALK | C0279682 | Bladder Adenocarcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0280217 | stage, non-small cell lung cancer | 0.0002747267842131 | BEFREE |
238 | ALK | C0334054 | cystic disease | 0.0002747267842131 | BEFREE |
238 | ALK | C0334233 | Pleomorphic carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0334254 | Lymphoepithelial carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0334607 | Psammomatous Meningioma | 0.0002747267842131 | BEFREE |
238 | ALK | C0334660 | Angioendotheliomatosis | 0.0002747267842131 | BEFREE |
238 | ALK | C0345967 | Malignant mesothelioma | 0.0002747267842131 | BEFREE |
238 | ALK | C0346053 | Atypical fibroxanthoma of skin | 0.0002747267842131 | BEFREE |
238 | ALK | C0346109 | Malignant Mesothelioma of Peritoneum | 0.0002747267842131 | BEFREE |
238 | ALK | C0346647 | Malignant neoplasm of pancreas | 0.0002747267842131 | BEFREE |
238 | ALK | C0347016 | Secondary malignant neoplasm of spinal cord | 0.0002747267842131 | BEFREE |
238 | ALK | C0349532 | Gastric lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0376358 | Malignant neoplasm of prostate | 0.0002747267842131 | BEFREE |
238 | ALK | C0424295 | Hyperactive behavior | 0.0002747267842131 | BEFREE |
238 | ALK | C0497327 | Dementia | 0.0002747267842131 | BEFREE |
238 | ALK | C0553580 | Ewings sarcoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0598935 | Tumor Initiation | 0.0002747267842131 | BEFREE |
238 | ALK | C0600139 | Prostate carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0677886 | Epithelial ovarian cancer | 0.0002747267842131 | BEFREE |
238 | ALK | C0699791 | Stomach Carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C0751688 | Malignant Squamous Cell Neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C0795801 | trisomy 2 | 0.0002747267842131 | BEFREE |
238 | ALK | C0836924 | Thrombocytosis | 0.0002747267842131 | BEFREE |
238 | ALK | C0854821 | Anaplastic large cell lymphoma T- and null-cell types refractory | 0.0002747267842131 | BEFREE |
238 | ALK | C0919267 | ovarian neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C1140680 | Malignant neoplasm of ovary | 0.0002747267842131 | BEFREE |
238 | ALK | C1145670 | Respiratory Failure | 0.0002747267842131 | BEFREE |
238 | ALK | C1258666 | Myxoid cyst | 0.0002747267842131 | BEFREE |
238 | ALK | C1266034 | Bronchiolo-alveolar carcinoma, non-mucinous | 0.0002747267842131 | BEFREE |
238 | ALK | C1279296 | Chronic leukemia (category) | 0.0002747267842131 | BEFREE |
238 | ALK | C1290375 | Mesothelioma (malignant, clinical disorder) (disorder) | 0.0002747267842131 | BEFREE |
238 | ALK | C1292769 | Precursor B-cell lymphoblastic leukemia | 0.0002747267842131 | BEFREE |
238 | ALK | C1301363 | Blastic plasmacytoid dendritic cell neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C1302772 | Primary cutaneous lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1319315 | Adenocarcinoma of large intestine | 0.0002747267842131 | BEFREE |
238 | ALK | C1332942 | Childhood Anaplastic Large Cell Lymphoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1333967 | Inflammatory pseudotumor of liver | 0.0002747267842131 | BEFREE |
238 | ALK | C1334699 | Mesenchymal Cell Neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C1334953 | Neuroblastic Tumor | 0.0002747267842131 | BEFREE |
238 | ALK | C1335433 | Pleural Carcinomatosis | 0.0002747267842131 | BEFREE |
238 | ALK | C1336052 | Spindle Cell Neoplasm | 0.0002747267842131 | BEFREE |
238 | ALK | C1336891 | Urinary Bladder Inflammatory Myofibroblastic Tumor | 0.0002747267842131 | BEFREE |
238 | ALK | C1337013 | Differentiated Thyroid Gland Carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1368683 | Epithelioma | 0.0002747267842131 | BEFREE |
238 | ALK | C1370723 | Stromal sarcoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1402294 | Primary Lesion | 0.0002747267842131 | BEFREE |
238 | ALK | C1514517 | Prostate Stromal Proliferation of Uncertain Malignant Potential | 0.0002747267842131 | BEFREE |
238 | ALK | C1519670 | Tumor Angiogenesis | 0.0002747267842131 | BEFREE |
238 | ALK | C1527390 | Neoplasms, Intracranial | 0.0002747267842131 | BEFREE |
238 | ALK | C1565489 | Renal Insufficiency | 0.0002747267842131 | BEFREE |
238 | ALK | C1708751 | Low grade myofibroblastic sarcoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1708781 | Lung Sarcomatoid Carcinoma | 0.0002747267842131 | BEFREE |
238 | ALK | C1709246 | Non-Neoplastic Disorder | 0.0002747267842131 | BEFREE |